1. Home
  2. ALTI vs TSHA Comparison

ALTI vs TSHA Comparison

Compare ALTI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$4.65

Market Cap

394.0M

Sector

Finance

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.76

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
TSHA
Founded
2020
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.0M
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ALTI
TSHA
Price
$4.65
$5.76
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$10.22
AVG Volume (30 Days)
172.8K
4.0M
Earning Date
11-12-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$226,717,000.00
$6,310,000.00
Revenue This Year
$19.78
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$1.05
52 Week High
$5.45
$5.96

Technical Indicators

Market Signals
Indicator
ALTI
TSHA
Relative Strength Index (RSI) 54.82 61.97
Support Level $4.73 $5.37
Resistance Level $5.20 $5.96
Average True Range (ATR) 0.36 0.32
MACD -0.03 0.02
Stochastic Oscillator 47.06 83.97

Price Performance

Historical Comparison
ALTI
TSHA

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: